Literature DB >> 28753772

Occupation and Bladder Cancer Phenotype: Identification of Workplace Patterns That Increase the Risk of Advanced Disease Beyond Overall Incidence.

Aidan P Noon1, Jan Ivar Martinsen2, James W F Catto3, Eero Pukkala4.   

Abstract

BACKGROUND: We examined a national data set to determine if workers employed in specific occupations develop distinct bladder cancer (BCa) phenotypes.
OBJECTIVE: To compare the incidence and disease-specific mortality (DSM) of localized and advanced BCa in workers with different job titles. DESIGN, SETTING, AND PARTICIPANTS: BCa incidence, stage at diagnosis, and DSM in 1.7 million Finnish men (13 717 with BCa) and 1.7 million women (4282 with BCa) with annotated occupational descriptions. Follow-up was 37 and 43 million person-years, respectively. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The gender-specific incidence and BCa DSM within each occupational category was compared with the expected number of cases based on the entire Finnish population to generate standardized incidence ratios (SIRs) and standard mortality ratios (SMRs). RESULTS AND LIMITATIONS: Occupations were found that had significant differences in the incidence of localized (SIRloc) and advanced (SIRadv, SMRadv) BCa and DSM. Male chemical process workers (SIRloc/SIRadv: 5.19; 95% confidence interval [CI], 1.73-25.7), male military personnel (SIRloc/SIRadv: 6.4; 95% CI, 1.09-259.0), and male public safety workers (SIRloc/SIRadv: 1.77; 95% CI, 1.04-3.23) had significantly more localized than advanced tumors. In contrast, miscellaneous construction workers had more advanced than localized cancers for both genders (male SIRloc/SIRadv: 0.67; 95% CI, 0.53-0.86; female SIRloc/SIRadv: 0.12; 95% CI, 0.09-0.54). Male chemical process workers had fewer deaths from BCa than expected from advanced tumors (SMRadv: 0.32; 95% CI, 0.07-0.94), and miscellaneous constructions workers had more deaths from advanced tumors than expected (male SMRadv: 1.44; 95% CI, 1.10-1.85; female SMRadv: 3.35; 95% CI, 1.23-7.30). Limitations of this study are failure to control accurately for the effects of smoking and a lack of specific treatment information.
CONCLUSIONS: Occupations exist that may differ in their risks for localized and advanced BCa and for DSM. PATIENT
SUMMARY: Occupations have been identified that may have different patterns of bladder cancer than expected. These findings may be explained by confounding factors such as exposure to tobacco smoke; however, it could be that workers with these job titles are exposed to specific bladder carcinogens.
Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Carcinogens; Industry; Occupations; Phenotype; Urinary bladder neoplasms; Workplace

Mesh:

Substances:

Year:  2016        PMID: 28753772     DOI: 10.1016/j.euf.2016.06.014

Source DB:  PubMed          Journal:  Eur Urol Focus        ISSN: 2405-4569


  8 in total

1.  Adenylate kinase 4 promotes bladder cancer cell proliferation and invasion.

Authors:  Feng Xin; Dong-Wei Yao; Li Fan; Jiu-Hua Liu; Xiao-Dong Liu
Journal:  Clin Exp Med       Date:  2019-08-28       Impact factor: 3.984

2.  The landscape of genetics and biomarkers in bladder cancer.

Authors:  Michael Rink
Journal:  Transl Androl Urol       Date:  2017-12

3.  Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes.

Authors:  James W F Catto; Amy Downing; Samantha Mason; Penny Wright; Kate Absolom; Sarah Bottomley; Luke Hounsome; Syed Hussain; Mohini Varughese; Caroline Raw; Phil Kelly; Adam W Glaser
Journal:  Eur Urol       Date:  2021-02-10       Impact factor: 20.096

4.  Health-related quality of life after treatment for bladder cancer in England.

Authors:  Samantha J Mason; Amy Downing; Penny Wright; Luke Hounsome; Sarah E Bottomley; Jessica Corner; Mike Richards; James W Catto; Adam W Glaser
Journal:  Br J Cancer       Date:  2018-05-14       Impact factor: 7.640

5.  Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes?

Authors:  Florian Janisch; Hang Yu; Malte W Vetterlein; Roland Dahlem; Oliver Engel; Margit Fisch; Shahrokh F Shariat; Armin Soave; Michael Rink
Journal:  J Clin Med       Date:  2019-09-13       Impact factor: 4.241

Review 6.  Bladder Cancer in Iran: An Epidemiological Review.

Authors:  Khadijeh Kalan Farmanfarma; Neda Mahdavifar; Hamid Salehiniya
Journal:  Res Rep Urol       Date:  2020-03-05

7.  Occupational disparities in bladder cancer survival: A population-based cancer registry study in Japan.

Authors:  Masayoshi Zaitsu; Hye-Eun Lee; Sangchul Lee; Takumi Takeuchi; Yasuki Kobayashi; Ichiro Kawachi
Journal:  Cancer Med       Date:  2019-12-11       Impact factor: 4.452

8.  Occupational bladder cancer: A cross section survey of previous employments, tasks and exposures matched to cancer phenotypes.

Authors:  Oliver Reed; Ibrahim Jubber; Jon Griffin; Aidan P Noon; Louise Goodwin; Syed Hussain; Marcus G Cumberbatch; James W F Catto
Journal:  PLoS One       Date:  2020-10-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.